Prospect and progress of gene therapy in treating atherosclerosis

Expert Opinion on Biological Therapy
Annukka M KiveläSeppo Ylä-Herttuala

Abstract

Despite considerable improvements in therapies, atherosclerotic cardiovascular diseases remain the leading cause of death worldwide. Therefore, in addition to current treatment options, new therapeutic approaches are still needed. In this review, novel gene and RNA interference-based therapy approaches and promising target genes for treating atherosclerosis are addressed. In addition, relevant animal models for the demonstration of the efficacy of different gene therapy applications, and current progress toward more efficient, targeted and safer gene transfer vectors are reviewed. Atherosclerosis represents a complex multifactorial disease that is dependent on the interplay between lipoprotein metabolism, cellular reactions and inflammation. Recent advances and novel targets, especially in the field of RNA interference-based therapies, are very promising. However, it should be noted that the modulation of a particular gene is not as clearly associated with a complex polygenic disease as it is in the case of monogenic diseases. A deeper understanding of molecular mechanisms of atherosclerosis, further progress in vector development and the demonstration of treatment efficacy in relevant animal models will be required before gene...Continue Reading

References

May 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·J A PiedrahitaN Maeda
Jan 1, 1985·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·V FusterE J Bowie
Mar 1, 1986·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·S Ylä-HerttualaH K Akerblom
Jul 1, 1995·Arteriosclerosis, Thrombosis, and Vascular Biology·V ClaveyJ C Fruchart
May 10, 1994·Proceedings of the National Academy of Sciences of the United States of America·S IshibashiM S Brown
Dec 1, 1993·The Journal of Clinical Investigation·M F LintonS G Young
Jan 1, 1993·Annual Review of Immunology·K W MooreT R Mosmann
Jan 17, 1997·Science·L Masucci-MagoulasA R Tall
Apr 17, 1998·Atherosclerosis·P LeppänenS Ylä-Herttuala
Oct 3, 1998·Circulation Research·M D RekhterM J Ryan
Oct 28, 1998·The Journal of Clinical Investigation·M M VéniantS G Young
Dec 19, 1998·Journal of the American College of Cardiology·C BustosJ Egido
Jun 26, 2001·Diabetes·R G GerrityT Kimsey
Nov 1, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·J H Von Der ThüsenE A Biessen
May 15, 2002·Current Biology : CB·Mariana Lagos-QuintanaThomas Tuschl
Mar 18, 2003·Journal of Lipid Research·Gustav Schonfeld
May 21, 2003·Gene Therapy·Q Liu, D A Muruve
Apr 20, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Hanna M KankkonenSeppo Ylä-Herttuala
Oct 19, 2005·Gene Therapy·R AlbaM Chillon
Feb 7, 2006·Cell Metabolism·Christine EsauBrett P Monia
Mar 28, 2006·Nature·Tracy S ZimmermannIan MacLachlan
Feb 13, 2007·Cardiovascular Revascularization Medicine : Including Molecular Interventions·Fumiaki IkenoAlan C Yeung
Aug 21, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Wen Qiang ChenYun Zhang
Mar 28, 2008·Nature·Joacim ElménSakari Kauppinen
Aug 13, 2008·Proceedings of the National Academy of Sciences of the United States of America·Maria Frank-KamenetskyKevin Fitzgerald
Oct 30, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Laurence CrombezGilles Divita
Dec 9, 2008·Journal of Lipid Research·Avani A PendseNobuyo Maeda

❮ Previous
Next ❯

Citations

Apr 12, 2016·Expert Opinion on Biological Therapy·Hao H ChenHoward Leong-Poi
Apr 10, 2018·Pharmaceutical Patent Analyst·Ambikanandan Misra
Nov 6, 2018·International Heart Journal·Shota TsuchidaTetsuo Minamino
Mar 4, 2020·Current Pharmaceutical Design·Igor A Sobenin, Vasily N Sukhorukov
Nov 19, 2019·Journal of Cellular Biochemistry·Lijie ZhuChuanyu Gao
Feb 9, 2020·Current Atherosclerosis Reports·Petri MäkinenSeppo Ylä-Herttuala

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

© 2021 Meta ULC. All rights reserved